Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-04-22 to 2022-05-13
Current total value of award: $9335.76
Description: 4557013231!ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML